SIFCO Industries (NYSEAM) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
5 Oct, 2026Executive summary
Q2 FY26 net sales rose to $26.4M from $19.0M; operating profit was $2.7M versus a $2.7M operating loss, reflecting volume, pricing, mix and overhead absorption gains.
H1 FY26 net sales increased to $50.4M from $39.9M, with continuing-operations income of $4.4M versus a $3.7M loss.
Financial highlights
Q2 net sales were $26.444M, gross profit $5.661M and operating profit $2.661M; net income was $2.651M versus a $1.392M net loss YoY.
H1 net sales were $50.417M, gross profit $10.850M and operating profit $5.224M; net income was $4.441M versus a $3.708M net loss YoY.
Diluted EPS was $0.43 in Q2 versus $(0.23) YoY, and $0.72 for H1 versus $(0.61).
Q2 SG&A was $3.0M, up from $2.4M, including environmental reserve and related legal costs; H1 SG&A was $5.6M versus $5.2M.
Outlook and guidance
Backlog was $157.7M at March 31, 2026, versus $129.2M a year earlier; orders may be modified or cancelled with limited charges, and backlog may not indicate future sales.
Remaining performance obligations were $157.719M; $95.322M are expected to be completed within 12 months.
FY26 remaining capital expenditures are expected at $1.0M–$1.4M, primarily for production capability, product offerings and cost reductions; $0.4M of capital commitments existed at March 31.
Management expects cash and available credit lines to fund operations and planned capex for 12 months; pension contributions of $160K are anticipated for the remainder of FY26.
Latest events from SIFCO Industries
- FY24 sales rose 20%, with $114.4M backlog driving increased production.NYSEAM
Q4 2024 - Sales rose 6%, continuing losses narrowed, and year-end backlog reached $119.2m.NYSEAM
Q4 2025 - H1 sales rose 10.9%, losses narrowed, and backlog reached $129.2M.NYSEAM
Q2 2025 - Q3 growth lifted earnings, but October debt maturity leaves refinancing risk unresolved.NYSEAM
Q3 2024 - Sales rose 35.0%, losses narrowed, and backlog reached $121.9M.NYSEAM
Q1 2025 - ERC benefits and aerospace demand lifted Q3 profit; backlog stood at $130.4M.NYSEAM
Q3 2025 - Four directors, auditor ratification and a pause in FY2025 long-term awards headline the proxy.NYSEAM
Proxy filing - Military demand lifted nine-month results and backlog, while Q3 earnings absorbed a $3.2 million LIFO impact.NYSEAM
Q3 2026 - Sales rose 14.8% as military demand drove a return to profit and backlog growth.NYSEAM
Q1 2026